Society of Hematologic Oncology Insider news

Dr. Roberto Mina on the pivotal phase 3 MajesTEC-9 trial in multiple myeloma

In this SOHO Insider podcast, host Saad Usmani, MD, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, spoke with Roberto Mina, MD, associate profess

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College of Wisconsin, on news from t

Dr. Iacoboni on improving CAR T-cell therapy outcomes in lymphoma

Gloria Iacoboni, MD, PhD, a hematologist at Vall d’Hebron University Hospital in Barcelona, Spain, spoke with Dr. James Day, a clinical research training fellow at UCL in

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

Prof. Amanda Goodall, director of the Executive Master’s in Medical Leadership (EMML), a specialized MSc degree from Bayes Business School offering advanced leadership tr

Prof. Cwynarski previews CNS, peripheral T-cell lymphoma sessions ahead of SOHO UK

Prof. Kate Cwynarski, MD, PhD, joined SOHO Insider podcast host Megan Melody, MD, for a discussion previewing lymphoma sessions she will lead at the inaugural SOHO UK mee

Public-private partnerships needed to sustain progress in blood cancer treatment

John DiPersio, MD, PhD, current president of SOHO and director of the Center for Gene and Cellular Immunotherapy at Washington University School of Medicine in St. Louis,

Drs. Melody, Phillips talk glofitamab in MCL

In this podcast episode recorded at the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), Megan Melody, MD, from Tampa General Hospital, spoke

Advances in essential thrombocythemia with Drs. Kuykendall, Tremblay

In this episode of the SOHO Insider podcast, Andrew Kuykendall, MD, assistant member at Moffitt Cancer Center, and Douglas Tremblay, MD, assistant professor of medicine a

Dr. Thomas Martin interviews 1st US patient treated with cilta-cel

In this episode of the SOHO Insider podcast, Thomas Martin, MD, professor of medicine at University of California, San Francisco, talks with patient Craig Chase, an Ameri

Tara Graff, DO, talks community care and the CAR-T vs bispecific debate

SOHO Insider lymphoma podcast host Megan Melody, MD, assistant professor at the University of South Florida, interviews Tara Graff, DO, director of clinical trials and ly

A 2025 lymphoma snapshot from Julie Vose, MD, MBA

Ahead of SOHO Breakthroughs in Blood Cancers—and in the spirit of end-of-year lists—SOHO Insider asked Dr. Vose for her take on the biggest lymphoma developments of 2025.

Does the future of myeloma treatment belong to trispecific antibodies?

In this SOHO Insider podcast, Saad Usmani, MD, chief of the myeloma service at Memorial Sloan Kettering Cancer Center, and Niels W C J van de Donk, MD, professor of hemat

Drs. O’Brien, Jain discuss FLAIR trial, BTK degraders in CLL

In this episode of the SOHO Insider podcast, Susan O’Brien, MD, a professor of medicine from the Chao Family Comprehensive Cancer Center at the University of California,

Sagar Lonial, MD, on what to expect at SOHO Breakthroughs in Blood Cancers

Sagar Lonial, MD, and Saad Usmani, MD, provide a sneak peek on what attendees can expect to learn at SOHO Breakthroughs in Blood Cancers (SBBC). Dr. Lonial will be the pr

Dr. Eytan Stein joins Dr. Saad Usmani on SOHO Insider podcast

Saad Usmani, MD, chief of the myeloma service and Eytan Stein, MD, chief of the leukemia service, both from Memorial Sloan Kettering Cancer Center, discuss menin inhibito

Drs. Kuykendall and Gerds discuss myelofibrosis anemia challenges

SOHO Insider myeloproliferative neoplasms podcast host Andrew Kuykendall, MD, associate member in the Department of Malignant Hematology at the Moffitt Cancer Center, and